The Hartford Financial Services Group, Inc. DEB FIX/FLT 42
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 Fundamental Analysis
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) shows weak financial fundamentals with a PE ratio of 1814.10, profit margin of 0.02%, and ROE of 0.03%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 18.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HGH's fundamental strength across five key dimensions:
Efficiency Score
WeakHGH struggles to generate sufficient returns from assets.
Valuation Score
ModerateHGH shows balanced valuation metrics.
Growth Score
WeakHGH faces weak or negative growth trends.
Financial Health Score
WeakHGH carries high financial risk with limited liquidity.
Profitability Score
WeakHGH struggles to sustain strong margins.
Key Financial Metrics
Is HGH Expensive or Cheap?
P/E Ratio
HGH trades at 1814.10 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, HGH's PEG of -18.15 indicates potential undervaluation.
Price to Book
The market values The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 at 366.66 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -2.04 times EBITDA. This is generally considered low.
How Well Does HGH Make Money?
Net Profit Margin
For every $100 in sales, The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 keeps $0.02 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.03 in profit for every $100 of shareholder equity.
ROA
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 generates $4.46 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $20.67 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
1814.10
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-18.15
vs 25 benchmark
P/B Ratio
Price to book value ratio
366.66
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
230.31
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.02
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How HGH Stacks Against Its Sector Peers
| Metric | HGH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 1814.10 | 18.80 | Worse (Expensive) |
| ROE | 0.03% | 817.00% | Weak |
| Net Margin | 0.02% | -55.00% (disorted) | Weak |
| Debt/Equity | 230.31 | 1.03 | Weak (High Leverage) |
| Current Ratio | 0.02 | 661.52 | Weak Liquidity |
| ROA | 4.46% | -23757.00% (disorted) | Weak |
HGH outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews The Hartford Financial Services Group, Inc. DEB FIX/FLT 42's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical